The Real-world Therapeutic Analysis of First-line Immunotherapy in Chinese Patients with Drive Gene Positive for Advanced Non-Small Cell Lung Cancer

Background: Immune checkpoint inhibitors (ICIs) are widely used for treating advanced non-small cell lung cancer (NSCLC). However, some studies indicate that patients with genetic mutations do not benefit from immunotherapy. Hence, this study explored the efficacy of anti-programmed death-1 (PD-1) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Li, Fuxia, Zhao, Jing, Zhuo, Xiaoli, Lai, Jingjiang, Wang, Jingliang, Jiang, Fengxian, Xu, Wei, Luan, Fang, Lin, Xiaoyan, Yang, Shuping, Fu, Guobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158514/
https://www.ncbi.nlm.nih.gov/pubmed/37151388
http://dx.doi.org/10.7150/jca.77199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158514/
https://www.ncbi.nlm.nih.gov/pubmed/37151388
http://dx.doi.org/10.7150/jca.77199

Ejemplares similares